Merck to Acquire SpringWorks Therapeutics in $3.9 Billion Deal Table of Contents Merck to Acquire SpringWorks Therapeutics in $3.9 Billion Deal Merck to Acquire SpringWorks Therapeutics in $3.9 Billion Deal Deal Details Financing and Future Impact SpringWorks Therapeutics: A profile Market Position Frequently Asked Questions (FAQ) Previous Discussions Executive Summary STAMFORD, Connecticut — May 20, … Read more
It isn’t a $3 T-shirt or an electronic gadget. It is a cancer drug her company discovered—one that has made her the face of a rising pharmaceutical star. When Xia founded her company with three colleagues in 2012, China had few labs capable of finding drugs on their own, while U.S. companies filled their research … Read more
Merck to Acquire Rights to Experimental Heart Drug Table of Contents Merck to Acquire Rights to Experimental Heart Drug Scientists Develop Modified Bacteria to Fight Tumors with Infrared light The Effects of Infrared Light Merck’s Investment in Experimental Heart Drug: A Q&A What is Merck’s Recent Investment in a Heart Drug? What is the Focus … Read more